Abstract:The dramatic increase in the use of nanoparticles (NP) in industry and research has raised questions about the potential toxicity of such materials. Unfortunately, not enough is known about how the novel, technologically-attractive properties of NPs correlate with the interactions that may take place at the nano/bio interface. The academic, industrial, and regulatory communities are actively seeking answers to the growing concerns on the impact of nanotechnology on humans. In this Account we adopt quantum dots (QDs) as an illustrative example of the difficulties associated with the development of a rational science-based approach to nanotoxicology. The optical properties of QDs are far superior to those of organic dyes in terms of emission and absorption bandwidths, quantum yield, and resistance to photobleaching. Moreover, QDs may be decorated with targeting moieties or drugs and, therefore, are candidates for site-specific medical imaging and for drug delivery, for example in cancer treatment. Earlier this year researchers demonstrated that QD-based imaging using monkeys caused no adverse effects although QDs accumulated in lymph nodes, bone marrow, liver, and spleen for up to 3 months after injection. Such persistence of QDs in live animals does, however, raise concerns about the safety of using QDs both in the laboratory and in the clinic. Researchers anticipate that QDs will be increasingly used not only in clinical applications but also in various manufactured products. For example, QD-solar cells have emerged as viable contenders to complement or replace dye-sensitized solar cells; CdTe/CdS thin film cells have already captured approximately 10 percent of the global market, and in addition, QDs can serve as components of sensors and as emitting materials in LEDs. Given the clear indications that QDs will inevitably become components of a wide range of manufactured and consumer products, researchers and policy makers need to understand the possible health risks associated with exposure to QDs. In this Account, we initially review the known mechanisms by which QDs can damage cells, including oxidative stress elicited by reactive oxygen species (ROS). We discuss lesser-known impairments induced in cells by nanomolar to picomolar concentrations of QDs, which imply that cadmium-containing QDs can exert genotoxic, epigenetic, and metalloestrogenic effects. These observations strongly suggest that minute concentrations of QDs could be sufficient to cause long lasting, even transgenerational, effects. We also consider various modes by which humans could be exposed to QDs in their work or through the environment. Although considerable advances have been made in enhancing the stability and overall quality of QDs, over time they can partially degrade in the environment or in biological systems, and eventually cause small, but cumulative undesirable effects. A combination of toxicological, genetic, epigenetic and imaging approaches is required to create comprehensive guidelines for evaluating the nanotoxicity of nanomaterials, including QDs. Prior to biological investigations with these materials, an indispensible step must be the full characterization of NPs by complementary techniques. Specifically, the concentration, size, charge, and ligand stability of NPs in biological media must be known if we are to understand fully how the properties of nanoparticles and of their biological environment contribute to cytotoxicity.

CdSe/ZnS Quantum Dots' Impact on In Vitro Actin Dynamics

Cytotoxicity of Quantum Dots in Receptor-Mediated Endocytic and Pinocytic Pathways in Yeast

An in vitro study of vascular endothelial toxicity of CdTe quantum dots.

The Influence on Cell Cycle and Cell Division by Various Cadmium-Containing Quantum Dots

In Vitro Cytotoxicity of CdSe/ZnS Quantum Dots with Different Surface Coatings to Human Keratinocytes HaCaT Cells

The effects of composition and surface chemistry on the toxicity of quantum dots.

Microenvironmental Impact on InP/ZnS-Based Quantum Dots in In Vitro Models and in Living Cells: Spectrally- and Time-Resolved Luminescence Analysis

Long-term exposure of CdTe quantum dots on PC12 cellular activity and the determination of optimum non-toxic concentrations for biological use

Acute toxicity of two CdSe/ZnSe quantum dots with different surface coating in Daphnia magna under various light conditions

Quantum Dots: the Influence on Cell Cycle and Cell Division by Various Cadmium‐Containing Quantum Dots (small 14/2013)

Acute Toxicity and Prothrombotic Effects of Quantum Dots: Impact of Surface Charge

The Cytotoxicity of Cadmium Based, Aqueous Phase - Synthesized, Quantum Dots and Its Modulation by Surface Coating

Unmodified CdSe Quantum Dots Induce Elevation of Cytoplasmic Calcium Levels and Impairment of Functional Properties of Sodium Channels in Rat Primary Cultured Hippocampal Neurons.

The Effect of Quantum Dots on Synaptic Transmission and Plasticity in the Hippocampal Dentate Gyrus Area of Anesthetized Rats

Quantum Dot-Affibody Fluorescence Probes for Single Molecule Tracking in Living Cell Membranes

Streptavidin-conjugated CdSe/ZnS quantum dots impaired synaptic plasticity and spatial memory process

New Insights into the Cellular Toxicity of Carbon Quantum Dots to Escherichia coli

The Cytotoxicity of Cadmium-Based Quantum Dots

Quantum dot cytotoxicity and ways to reduce it

Assessment of cytocompatibility of surface-modified CdSe/ZnSe quantum dots for BALB/3T3 fibroblast cells

Fate of CdSe/ZnS Quantum Dots in Cells: Endocytosis, Translocation and Exocytosis